Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

Overview of the Vascular System

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

Development of Blood Vessels

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes.

Journal of neuroinflammation·2012

Same author

DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study.

Diabetes research and clinical practice·2012

Same author

Tight controlled expression and secretion of Lactobacillus brevis SlpA in Lactococcus lactis.

Biotechnology letters·2012

Same author

Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats.

Neurotoxicity research·2012

Same author

Microbial keratitis in Gujarat, Western India: findings from 200 cases.

The Pan African medical journal·2012

Same author

Silver triflate catalyzed synthesis of 3-aminoalkylated indoles and evaluation of their antibacterial activities.

Organic and medicinal chemistry letters·2012

Search research articles

Related Experiment Video

Updated: May 26, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Complicated life, complicated VEGF-B.

Xuri Li¹, Anil Kumar, Fan Zhang

¹National Eye Institute, National Institutes of Health, Rockville, MD 20852, USA. lixur@nei.nih.gov

Trends in Molecular Medicine

|December 20, 2011

Summary

Vascular Endothelial Growth Factor-B (VEGF-B) is not a typical growth factor, as its absence shows normal growth in mice. This review explores VEGF-B's complex roles and therapeutic potential.

More Related Videos

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

In Vitro Model of Coronary Angiogenesis

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

Related Experiment Videos

Last Updated: May 26, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

In Vitro Model of Coronary Angiogenesis

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

Area of Science:

Molecular Biology
Cell Biology
Biochemistry

Background:

Vascular Endothelial Growth Factor-B (VEGF-B) is a poorly understood member of the VEGF family.
Despite its name, VEGF-B does not appear to be a primary growth factor, as evidenced by normal growth in VEGF-B deficient mice.
Its role in angiogenesis is contradictory, with some studies showing pro-angiogenic effects and others demonstrating anti-angiogenic or anti-tumorigenic properties.

Purpose of the Study:

To review recent advancements in understanding VEGF-B biology.
To discuss the multifaceted roles of VEGF-B.
To explore the underlying mechanisms and potential therapeutic implications of VEGF-B.

Main Methods:

Literature review of recent research on VEGF-B.
Analysis of studies investigating VEGF-B's function in various biological contexts.
Synthesis of findings to elucidate VEGF-B's mechanisms of action.

Main Results:

VEGF-B's function is complex and context-dependent, deviating from typical growth factor or angiogenic factor roles.
VEGF-B can exhibit both pro-angiogenic and anti-angiogenic activities under different conditions.
Evidence suggests VEGF-B may inhibit tumor growth and angiogenesis in certain scenarios.

Conclusions:

The biological function of VEGF-B remains enigmatic due to its contradictory roles.
Further research is needed to fully elucidate the mechanisms governing VEGF-B's diverse functions.
Understanding VEGF-B's multifaceted roles may unlock novel therapeutic strategies.